01 1Qilu Antibiotics Pharmaceutical Co., Ltd.
01 1CEFEPIME FOR INJECTION
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-17
Pay. Date : 2013-08-07
DMF Number : 25303
Submission : 2011-09-15
Status : Active
Type : II
20
Qilu Antibiotics Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CEFEPIME FOR INJECTION, with a corresponding US DMF Number 25303.
Remarkably, this DMF maintains an Active status since its submission on September 15, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 17, 2013, and payment made on August 07, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
